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Summary
We wanted to assess the distribution of patients and to quantify the travel expenses for specialists’ consultation in 
cancer care. From 1st to 31st October 2018 specialists consulted 2856 with the malignant disease at University Hospital for 
Tumors. We looked at rectal cancer (C20) specifi cally and identifi ed 163 rectal cancer patients. Travel expenses are derived 
from the following:1,35 € per kilometer for patients outside of the city of Zagreb, as denoted by the county they live in, and 
minimal public transport fee for the patients residing in Zagreb (2,70 €). Cost of their return transport within Zagreb was 
313,2 € while 21362,16 € costed the return transport to and from the hospital from outside of Zagreb. The average cost per 
patient per visit 132,98 €. An estimate for 2856 patients is 379784,22 €. Transport cost for a patient being consulted on cancer 
care is a substantial part of not recognized costs in system analysis. The process of assessing travel costs display the area of 
gravitation toward a cancer center. 36% of patients were from Zagreb.
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ARGUMENT ZA JEDNODNEVNO PRAĆENJE BOLESNIKA S RAKOM
Sažetak
Procjenili smo distribuciju bolesnika i kvantifi cirali putne troškove savjetovanja specijalista u liječenju raka. Od 1. do 
31. listopada 2018. konzultirano je 2856 osoba s malignim bolestima, od toga 163 s rakom rektuma Putni troškovi iznosili su: 
1,35 € po kilometru za one izvan Zagreba i 2,70 € za javni prijevoz onih u Zagrebu. Ukupni troškovi povratnog prijevoza u 
Zagrebu iznosili su 313,2 €, dok je 21362,16 € koštao povratni prijevoz za bolesnike izvan Zagreba. Prosječna cijena po osobi 
i po dolasku iznosila je 132,98 €. Procjena za 2856 bolesnika je 379784,22 €.Troškovi prijevoza za one koji se savjetuju o njezi 
karcinoma predstavljaju značajan dio nepriznatih troškova u analizi sustava. Proces procjene troškova putovanja usputno 
prikazuje područje gravitiranja pacijenata prema centru za maligne bolesti. Oko 36% bolesnika je iz Zagreba.
KLJUČNE RIJEČI: rak, troškovi prijevoza, praćenje
INTRODUCTION
Cancer incidence in Croatia is rising being 
over 22 000 annually (1). Half of the patients who 
underwent surgery or chemoradiotherapy with 
curative intent while the other half will undergo 
palliative treatments or supportive care. In both 
scenarios, each diagnosed patient will be under 
surveillance: three to four times per year during 
the fi rst two years, and then twice a year for the 
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next three years. Usually, one or two specialists 
(surgeon/ oncologist/ nutritional support/ pain 
management) see the patient at those visits on a 
separate day, and the patient is required to bring 
along new laboratory exams, tumor markers and 
often ultrasound exam of the region most proba-
bly aff ected by recurrences or metastasis (2,3). 
Some of these exams can be scheduled into one 
hospital visit, but at the moment the most com-
mon scenario is that patient needs at least three 
days to do all the required exams.
In 2015 we initiated One Day Clinic - a pro-
gram for the diagnosis of breast cancer within 
one-day with the complete workup (4). The idea 
of one-day/one-stop diagnostics has been tested 
mostly on breast cancer (4,6) but has been tested 
on other cancers as well, for example, urological 
cancers (3). In 2015, Croatian Ministry of Health 
initiated a 72h diagnostic scheme which improved 
the time track of cancer diagnostics during eight 
months it existed. Unfortunately, with the transi-
tion to the following government, the program 
was discontinued and was never evaluated in de-
tail. However, during the execution of the Pro-
gram, and One-day breast diagnostics we learned 
that with minor changes in the organization we 
gained a lot in timely diagnosis and in limiting 
early patients’ distress when dealing with the di-
agnosis.
In case the patients could do the follow up 
within one day, through the one-day hospital, 
they would save two full days of their time (work-
ing days in some cases), plus the costs of transport 
and sick leave for those who work. From the hos-
pital perspective, this would require adjustments 
of already existing slots for radiology exams and 
laboratory or a bit of extra work for the informa-
tion technology department (IT department).
MATERIALS AND METHODS
To quantify the fi nancial eff ect, we performed 
a simple calculus: we looked at the current outpa-
tient consultancy fl ow. In October 2018, specialists 
consulted 5328 patients; 2856 patients with Inter-
national Statistical Classifi cation of Diseases and 
Related Health Problems (ICD-10) classifi cation C 
diagnosis. Since we are a referral center for rectal 
cancer treatment, we decided to look at C20 diag-
nosis (which stands for rectal cancer). Specialists 
consulted 163 rectal cancer patients, of which 58 
were from Zagreb and 95 were from other parts of 
Table 1.
DEPICTS THE COST BASED ON THE COMPENSATION AVAILABLE FROM THE COUNTY HEALTH CENTER AND ESTIMATED 
PUBLIC TRANSPORT COSTS FOR THE CITY OF ZAGREB. 
Location Distance in kilometers
Number of consultations 
(patients)
Cost in euros* 
one way
Cost in euros* 
return
Cost in kunas** 
one way
Cost in kunas** 
return
Zagreb 0 to 10 357(355) 481,95 963,9 3570 7140
Minimal distance 12 16,2 32,4 120 240
Maximal distance 457 616,95 1233,9 4570 9140
Average distance 83,2 112,32 224,64 832 1664
Out of Zagreb 12 to 457 163 (154) 18308,16 36616,32 135616 271232
* calculated using 1 € = 7.4 HRK
** reimbursement is 10 HRK per kilometer travelled
Figure 1. Distribution of patients consulted for rectal cancer in 
the outpatient clinic in one month period.
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Croatia. Patients receive a refund from their coun-
ty for the travel expenses or cover the costs them-
selves in case they live in Zagreb (one-quarter of 
Croatian population lives in Zagreb). The refund 
is calculated as a roundtrip and varies from 8-10 
HRK per kilometer (the equivalent of 1,08-1,35 €) 
depending on the resolution of the county which 
is in charge of the refund. Patients from the city of 
Zagreb are not refunded but are estimated to 
spend 20 HRK (2,70 €) per visit, on public trans-
port. We could not calculate the leave of absence 
because of the variable usage of the non-working 
option in cancer survivors.
RESULTS
The patients consulted for rectal cancer were 
mostly from the central part of Croatia with few 
exceptions gravitating away from their regional 
university hospital centers (Figure 1.).
DISCUSSION
Transportation of patients to specialist con-
sultation is an excellent way to check on cancer 
center area of att raction and resources consump-
tion of the system. In our patient sample, we quan-
tifi ed often disregarded aspect of care. The cost of 
the exams is covered by Croatian Health Insur-
ance Fund and is constant in public medical ser-
vices across Croatia so that it could have been 
omitt ed from the calculus. There is also no avail-
able data on waiting times within the premises for 
each exam patients need to perform. Furthermore, 
to catch the treatable recurrences or metastases we 
know will appear we need to have a more stan-
dardized follow-up and more comfortable for pa-
tients’ compliance.
As a result, we believe that small interven-
tions in the coordination of follow-up require-
ments would improve compliance and reduce the 
costs of the system. One solution has been imple-
mented in one-day/one-stop diagnostic clinics for 
various cancer sites. Through our experience with 
one-day diagnostics and the experience of others 
(1,4), the biggest challenge is changing the mind-
set of people involved in cancer care processes. 
Administrators at receptions and nurses often 
have to ‘guide’ patients from one stop in the diag-
nostic pathway to another.
The other option is merely using the technol-
ogy for the follow up of patients living away from 
the hospital. Introduction of telephone/video calls 
as an offi  cial mean of coordinating diagnostics 
and delivering further treatment/surveillance 
guidance should be considered a valid alternative 
option. The pilots of these alternative processes 
are tested for continuous cancer care (8).
Finally, part of the cancer survivors care is 
transferred to general practitioners and systems of 
support when discharged from the hospital but 
communicating with specialists when needed: the 
term for this is aftercare. Despite being at the bot-
tom of the European cancer survival scale, we still 
witness cancer becoming a chronic disease, and 
these steps are essential to rehabilitate the pa-
tients, treat the possible recurrences timely for 
them not to aff ect the overall survival.
Some services have to be delivered on site, 
while for others locally relevant online informa-
tion could be the solution. Supportive care no lon-
ger comprises only of diagnostics: sexual dysfunc-
tions, psychosocial eff ects, family and children 
support, rehabilitation and reintegration options 
need to be addressed as well. Respecting the pa-
tients’ time by structuring and coordinated one-
stop initial aftercare might be the humane way to 
deliver all the information and ensure the compli-
ance of the follow-up. A one-stop approach to sur-
veillance should not compromise the quality of 
care based on one stop diagnostics experience 
(5,6). To sum up, the landmark publication of the 
Institute of Medicine, Crossing the Quality Chasm, 
defi nes high-quality cancer care as eff ective, effi  -
cient, safe, patient-centered, timely and equitable 
(4). We used travel table to illustrated time, money 
and eff ort patients currently have to make for one 
consultation.
CONCLUSION
Transport cost for a patient being consulted 
on cancer care is a substantial part of not recog-
nized costs in system analysis. The process of as-
sessing travel costs display the area of gravitation 
toward a cancer center
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